Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Vildagliptin I.P. 50mg + Metformin HCL I.P. 1000mg Tablets
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*15
Price
₹308/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Validaplit M Forte Tablet is a potent combination of Vildagliptin 50mg and Metformin Hydrochloride 1000mg, formulated to manage type 2 diabetes mellitus effectively. Vildagliptin is a DPP-4 inhibitor that enhances the levels of incretin hormones, promoting increased insulin secretion and reduced glucagon release in a glucose-dependent manner. Metformin Hydrochloride, a biguanide, reduces hepatic glucose production and improves peripheral insulin sensitivity, thereby lowering blood glucose levels. Together, this combination provides complementary mechanisms of action that help achieve better glycemic control with a reduced risk of hypoglycemia. Validaplit M Forte supports improved insulin function and glucose metabolism, making it suitable for patients requiring intensified treatment alongside diet and exercise.
Common side effects may include gastrointestinal discomfort such as nausea, vomiting, diarrhea, and abdominal pain, mostly due to Metformin. Vildagliptin is generally well tolerated but can cause headache or dizziness in some cases. Rarely, hypoglycemia may occur, particularly if used with other antidiabetic medications.
Indicated for the treatment of type 2 diabetes mellitus, especially when monotherapy with Metformin or Vildagliptin alone does not provide adequate glycemic control.
Not recommended for patients with type 1 diabetes, diabetic ketoacidosis, or severe renal impairment. Regular monitoring of blood glucose and renal function is advised. Use with caution in patients with liver disorders. Consult a healthcare professional before use during pregnancy or breastfeeding.
Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 1000mg Tablets
Composition : Dapagliflozin Propanediol Monohydrate 10mg + Vildagliptin I.P. 100mg Tablets
Composition : Metformin 1000mg (S.R.) Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Vlidaplit M Forte Tablet has strong demand in the anti-diabetic and metabolic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on diabetology and chronic-care portfolios.
Medical distributors and agencies can benefit from consistent demand for management of type 2 diabetes mellitus, uncontrolled blood sugar levels, insulin resistance, and metabolic disorders. Vildagliptin 50mg helps improve insulin secretion and supports better blood glucose control Metformin HCL 1000mg helps reduce glucose production and improve insulin sensitivity Together, they provide effective glycemic control and strengthen a reliable anti-diabetic portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Vlidaplit M Forte Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong diabetologist and physician prescriptions, chronic long-term therapy demand, growing diabetic-care market, reliable supply chain support, and good margins in anti-diabetic medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.